Rivaroxaban is a new generation oral anticoagulant designed to replace warfarin therapy. The anti-factor Xa assay is used to monitor Rivaroxaban.
Tube
05 (CP) – Citrate
ID
12727
Availability
Weekdays
Additional Information
Rivaroxaban therapy does not usually require monitoring. Some patients however, may require levels to be monitored.
Send to
Specialist Coagulation
Chancellor / Lincoln Wing Link Corridor
Pathology
Block 32
St James University Hospital
Beckett Street
Leeds
LS9 7TF
Contact
Advice
Collection Con
1 x Citrate tube filled to the line.
Samples must be processed within 6 hours of being taken.
Sample REQ
Blood.
Ref. Range Notes
Critical action limit >550ng/mL
Units
ng/mL
IP Acute TAT
4 hours from receipt.
IP Routine TAT
24 hours.
GP Acute TAT
Contact laboratory
GP Routine TAT
24 hours